10x Genomics, Inc. — Director's Dealing 2022

Nov 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2022-11-22

Reporting Person: Saxonov Serge (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-22	Class A Common Stock	S	789	$34.0649	Disposed	976813	Direct
2022-11-22	Class A Common Stock	S	1887	$34.0653	Disposed	974926	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	2487	Indirect
Class A Common Stock	89960	Indirect

Footnotes

F1: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

F2: The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.

F3: The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.